Dr. Lucinda R. Hittle

Merck & Co


Lucinda Hittle began her career in mass spectrometry at the Indiana University high school student summer institute working with Dr. Ken Busch. She went on to obtain her B.S. Chemistry from Indiana University. She received her Ph.D. in Analytical Chemistry in 1994 from the University of Pittsburgh under the direction of Professor David M. Hercules. She then worked with Professor Franz Hillenkamp at the University of Muenster, Germany as an Alexander von Humboldt postdoctoral fellow. She began work in 1996 with Parke-Davis Pharmaceutical Research in the Pharmaceutical Delivery Systems, Analytical Research division in Morris Plains, NJ. From 1999-2007, Lucinda worked in the Pharmacokinetics, Dynamics & Metabolism department within Parke-Davis, Ann Arbor, MI which became Pfizer Global Research and Development. Lucinda joined Merck in 2007 and currently is Director of the PPDM Transporters and In Vitro Technologies Group, which focuses on interrogating questions of drug metabolism and disposition for small molecule and peptide projects. Over the course of her career, Lucinda has been involved in drug discovery and development programs in disease areas including oncology, diabetes, cardiovascular, inflammation, neuroscience, dermatology, and infectious diseases. She has contributed to the filing of marketed products including palbociclib (IbranceTM) and posaconazole (NoxafilTM). She is currently the Bioanalytical Lead for Merck’s V160 clinical vaccine research program to prevent the transmission of Cytomegalovirus (CMV) to newborns.

Lucinda has served as an adjunct faculty member for Stevens Institute of Technology, Hoboken, NJ. Lucinda has served as the American Society for Mass Spectrometry DMPK interest group coordinator from 2008-2010 and was elected to the Board of Directors as treasurer from 2010-2012. She is currently co-chair of the ASMS Career Development interest group and has served on the Nominating and multiple award committees. She has authored more than 30 research articles and book chapters. Her research interests include mass spectrometry, bioanalysis, and innovative methods to increase the quality and rigor of in vitro and in vivo experiments.